News

York Water Company Delivers 2024 Financial Performance Insights

York Water Company Delivers 2024 Financial Performance Insights

York Water Company 2024 Financial Results Overview

The York Water Company has recently shared its financial performance results for the year 2024, highlighting both achievements and challenges. JT Hand, the President and CEO of the company, emphasized the noteworthy aspects of their annual performance that included a mixture of increases in revenue and a dip in net income.

Revenue Growth and Income Adjustments

For the year 2024, the York Water Company reported operating revenues of $74,959,000, marking an increase of $3,928,000 compared to the previous year. However, the net income was recorded at $20,325,000, reflecting a decrease of $3,432,000 from 2023. Basics and diluted earnings per share stood at $1.42 for 2024, which was a decline of $0.24 on the preceding year. Despite the decline in net income, dividends per share rose by 4%, showcasing the company's commitment to returning value to its shareholders.

The primary reason behind the increase in revenues included a rise in service rates that took effect early in 2023, additional funds from the Distribution System Improvement Charge (DSIC), and an expanding customer base. The DSIC is a charge permitted by the Public Utility Commission that allows water utilities to collect funds from customers for the necessary replacement of aging infrastructure that is critical to service delivery.

Investment in Infrastructure Development

Throughout the year, the York Water Company made significant investments totaling $48.2 million aimed at improving its infrastructure. This includes ongoing projects such as armoring and replacing portions of the spillway at the Lake Williams dam, upgrading the wastewater treatment plant, and various other essential replacements and improvements to the water distribution system. Approximately 50,200 feet of old pipe were replaced in an effort to enhance service reliability, reduce operational costs, and ultimately improve customer satisfaction.

Fourth Quarter Financial Summary

Focusing specifically on the fourth quarter of 2024, the company experienced a slight revenue boost with an increase of $770,000. Nevertheless, net income for this period saw a decrease of $870,000 compared to the same quarter in 2023. Basic and diluted earnings per share for the fourth quarter were reported at $0.36, down by $0.06 from the previous year. The revenue increase again stemmed largely from the revenues associated with the DSIC and an expanding customer base, yet like previous quarters, it was unable to offset the impacts of heightened operational costs and other expenses.

Future Capital Expenditure Plans

Looking ahead, York Water has ambitious plans for continued investment in its infrastructure to support the growing demands of its customer base. The company has committed to investing approximately $46.0 million in 2025, followed by a planned investment of $48.5 million in 2026. These investments will focus on further extending water mains, replacing water tanks, constructing additional wastewater treatment facilities, enhancing the enterprise software system, and performing routine upgrades to existing distribution networks and service lines.

Final Thoughts on 2024 Performance

Despite facing some challenges with net income reduction in 2024, the York Water Company remains steadfast in its strategy to enhance service quality and infrastructure reliability for customers. The leadership looks forward to implementing planned investments which are essential in maintaining a dependable supply of drinking water and effective wastewater management.

Frequently Asked Questions

What were the main financial highlights for York Water Company in 2024?

In 2024, the York Water Company reported revenues of $74,959,000 and net income of $20,325,000, with earnings per share at $1.42.

How much did York Water plan to invest in infrastructure?

The company plans to invest approximately $46.0 million in 2025 and $48.5 million in 2026 for various infrastructure improvements.

What contributed to the revenue increase?

The revenue growth was primarily due to a rate increase effective March 2023, additional revenue from the DSIC, and an expanding customer base.

What was the status of dividends per share?

Dividends per share increased by 4% in 2024 compared to the previous year, reaching $0.8516 for the year.

How did operating expenses impact the company's income?

Although revenues increased, higher operational costs, maintenance expenses, and other factors resulted in a decrease in net income for the year.

Contact Information:
JT Hand, President & CEO
Email: jth@yorkwater.com

-OR-
Matthew E. Poff, CFO
Email: matthewp@yorkwater.com

Phone: 717-845-3601

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 156

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading